Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system-Reference-Cited by-同舟云学术

Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system

Published:2011-02 Issue:3 Volume:149 Page:292-298
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Medina Oula Penate,Pillarsetty Nagavarakishore,Glekas Athanasios,Punzalan Blesida,Longo Valerie,Gönen Mithat,Zanzonico Pat,Smith-Jones Peter,Larson Steven M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference27 articles.

1. E. Mishani, A. Hagooly, Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer. J. Nucl. Med. 50 (8) (2009) 1199-1202.

2. Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry;Tolmachev;J. Nucl. Med.,2009

3. Molecular imaging of epidermal growth factor receptor expression-activity at the kinase level in tumors with positron emission tomography;Gelovani;Cancer Metastasis Rev.,2008

4. Novel carbon-11 labeled 4-dimethyl-amino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors;Mishani;Nucl. Med. Biol.,2004

5. Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA—a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas;Pal;Mol. Imaging Biol.,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging drug delivery to the lungs: Methods and applications in oncology;Advanced Drug Delivery Reviews;2023-01

2. Synthesis of Prussian Blue Nanoparticles and Their Antibacterial, Antiinflammation and Antitumor Applications;Pharmaceuticals;2022-06-21

3. Transforming Nuclear Medicine with Nanoradiopharmaceuticals;ACS Nano;2022-03-16

4. Multimodal Targeted Nanoparticle-Based Delivery System for Pancreatic Tumor Imaging in Cellular and Animal Models;Current Pharmaceutical Design;2022-02

5. Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous in vivo delivery of tyrosine kinase inhibitors and kinase activity biosensors;Nanoscale;2021